FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3097113656> ?p ?o ?g. }

• W3097113656 endingPage "3149" @default.
• W3097113656 startingPage "3149" @default.
• W3097113656 abstract "CAP7.1 is a novel topoisomerase II inhibitor, converted to active etoposide via carboxylesterase 2 (CES2), with signals of efficacy in treatment-refractory solid tumours. In a Phase II trial, 27 patients with advanced biliary tract cancers (BTC) were randomised 1:1 to CAP7.1 plus best supportive care (BSC), or BSC alone, with crossover to CAP7.1 upon disease progression. The primary objective was disease control rate (DCR) following 28-day cycles of CAP7.1 (200/150 mg/m2; iv), or BSC until progression. Secondary objectives included progression-free survival (PFS), time-to-treatment failure (TTF), overall survival (OS) and safety. Fourteen patients received CAP7.1 and 13 BSC. DCR favoured CAP7.1 vs. BSC (50% vs. 20%; treatment difference: 30%, 95%CI −18.44, 69.22, full analysis set [FAS]), with disease progression in 40% vs. 70%, respectively. Significantly longer median PFS was achieved for CAP7.1 vs. BSC: 66 vs. 39 days, respectively (hazard ratio [HR] 0.31; 95%CI 0.11, 0.86; p = 0.009; FAS). Similar trends were observed for TTF and OS. CES2-positive patients had longer median PFS (158 vs. 56 days) and OS (228 vs. 82 days) vs. CES2-negative patients. Adverse events were predictable, dose-dependent and consistent with those previously observed with etoposide. These efficacy and safety findings in second-line BTC warrant further clinical investigation of CAP7.1." @default.
• W3097113656 created "2020-11-09" @default.
• W3097113656 creator A5007861447 @default.
• W3097113656 creator A5027680270 @default.
• W3097113656 creator A5028105168 @default.
• W3097113656 creator A5029305848 @default.
• W3097113656 creator A5031740501 @default.
• W3097113656 creator A5042249311 @default.
• W3097113656 creator A5046696433 @default.
• W3097113656 creator A5049518897 @default.
• W3097113656 creator A5050403610 @default.
• W3097113656 creator A5052578346 @default.
• W3097113656 creator A5057423807 @default.
• W3097113656 creator A5059581773 @default.
• W3097113656 creator A5070481872 @default.
• W3097113656 creator A5079645039 @default.
• W3097113656 creator A5085332368 @default.
• W3097113656 creator A5091399207 @default.
• W3097113656 date "2020-10-27" @default.
• W3097113656 modified "2023-10-02" @default.
• W3097113656 title "Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II Study" @default.
• W3097113656 cites W1955033393 @default.
• W3097113656 cites W1981226488 @default.
• W3097113656 cites W2011387799 @default.
• W3097113656 cites W2017044840 @default.
• W3097113656 cites W2033567537 @default.
• W3097113656 cites W2050632720 @default.
• W3097113656 cites W2059707463 @default.
• W3097113656 cites W2061251964 @default.
• W3097113656 cites W2089641077 @default.
• W3097113656 cites W2090221787 @default.
• W3097113656 cites W2093388808 @default.
• W3097113656 cites W2106550415 @default.
• W3097113656 cites W2125387002 @default.
• W3097113656 cites W2128889451 @default.
• W3097113656 cites W2137591261 @default.
• W3097113656 cites W2141078344 @default.
• W3097113656 cites W2284061749 @default.
• W3097113656 cites W2294765885 @default.
• W3097113656 cites W2312265484 @default.
• W3097113656 cites W2319818049 @default.
• W3097113656 cites W2522030210 @default.
• W3097113656 cites W2526881395 @default.
• W3097113656 cites W2553739594 @default.
• W3097113656 cites W2615950465 @default.
• W3097113656 cites W2620457065 @default.
• W3097113656 cites W2753051611 @default.
• W3097113656 cites W2782744916 @default.
• W3097113656 cites W2921485993 @default.
• W3097113656 cites W2947109943 @default.
• W3097113656 cites W3046934284 @default.
• W3097113656 doi "https://doi.org/10.3390/cancers12113149" @default.
• W3097113656 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7692271" @default.
• W3097113656 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33121007" @default.
• W3097113656 hasPublicationYear "2020" @default.
• W3097113656 type Work @default.
• W3097113656 sameAs 3097113656 @default.
• W3097113656 citedByCount "1" @default.
• W3097113656 countsByYear W30971136562021 @default.
• W3097113656 crossrefType "journal-article" @default.
• W3097113656 hasAuthorship W3097113656A5007861447 @default.
• W3097113656 hasAuthorship W3097113656A5027680270 @default.
• W3097113656 hasAuthorship W3097113656A5028105168 @default.
• W3097113656 hasAuthorship W3097113656A5029305848 @default.
• W3097113656 hasAuthorship W3097113656A5031740501 @default.
• W3097113656 hasAuthorship W3097113656A5042249311 @default.
• W3097113656 hasAuthorship W3097113656A5046696433 @default.
• W3097113656 hasAuthorship W3097113656A5049518897 @default.
• W3097113656 hasAuthorship W3097113656A5050403610 @default.
• W3097113656 hasAuthorship W3097113656A5052578346 @default.
• W3097113656 hasAuthorship W3097113656A5057423807 @default.
• W3097113656 hasAuthorship W3097113656A5059581773 @default.
• W3097113656 hasAuthorship W3097113656A5070481872 @default.
• W3097113656 hasAuthorship W3097113656A5079645039 @default.
• W3097113656 hasAuthorship W3097113656A5085332368 @default.
• W3097113656 hasAuthorship W3097113656A5091399207 @default.
• W3097113656 hasBestOaLocation W30971136561 @default.
• W3097113656 hasConcept C121332964 @default.
• W3097113656 hasConcept C126322002 @default.
• W3097113656 hasConcept C141071460 @default.
• W3097113656 hasConcept C142424586 @default.
• W3097113656 hasConcept C143998085 @default.
• W3097113656 hasConcept C197934379 @default.
• W3097113656 hasConcept C207103383 @default.
• W3097113656 hasConcept C2776694085 @default.
• W3097113656 hasConcept C2778119113 @default.
• W3097113656 hasConcept C2780739268 @default.
• W3097113656 hasConcept C44249647 @default.
• W3097113656 hasConcept C71924100 @default.
• W3097113656 hasConcept C87355193 @default.
• W3097113656 hasConcept C90924648 @default.
• W3097113656 hasConceptScore W3097113656C121332964 @default.
• W3097113656 hasConceptScore W3097113656C126322002 @default.
• W3097113656 hasConceptScore W3097113656C141071460 @default.
• W3097113656 hasConceptScore W3097113656C142424586 @default.
• W3097113656 hasConceptScore W3097113656C143998085 @default.
• W3097113656 hasConceptScore W3097113656C197934379 @default.
• W3097113656 hasConceptScore W3097113656C207103383 @default.

• next